Loncastuximab tesirine

Cat. No.: IBDI-431973

Loncastuximab tesirine is a human cluster of differentiation 19 (CD19)-directed antibody-drug conjugate (ADC). Once bound to CD19 on the cell membrane, loncastuximab tesirine is rapidly internalised and triggers cell death. Loncastuximab tesirin induces cell apoptosis, it can be used for the research of diffuse large B-cell lymphoma.

Product Details

Target	Antibody-Drug Conjugates (ADCs) | Apoptosis
Synonyms	Loncastuximab tesirine-lpyl, ADCT-402
SMILES	[Loncastuximab tesirine]

Storage & Handling

Storage	Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status	This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.